Gilead Sciences

Gilead Sciences’ annual HIV prevention injection shows promise in clinical trial, Lancet study reveals

The drug, which works by blocking HIV from entering and multiplying in human cells, remained in the body for at…

March 12, 2025 17:05 IST

Hetero enters into agreement with Gilead to manufacture and distribute multi drug-resistant HIV

Hetero enters into agreement with Gilead to manufacture and distribute HIV drug

Lenacapavir was approved for use in HIV-positive adults with multi-drug resistance by the European Union in August 2022 and received…

October 3, 2024 12:49 IST

Gilead, COVID-19, European Union, European Commission, health news, covid news,

EU signs COVID-19 drug procurement deal with Gilead

Altogether, 22 EU member states and countries are participating in the joint procurement, under which they can purchase up to…

July 20, 2022 18:59 IST

Many Janaushadhi Kendras accept orders on WhatsApp, e-mail to facilitate access to medicines during covid19 lockdown

Jubilant Life Sciences share price up 83% since March, inks pact with Gilead for potential coronavirus cure

The rally that pharmaceutical companies have witnessed on Dalal Street in the past few months has seen a lot of…

Updated: May 13, 2020 11:32 IST

Natco settles patent suit with Gilead, others

Under the terms of the settlement, Natco’s partner Alvogen will be able to market the oseltamivir phosphate capsules Natco Pharma…

December 14, 2015 16:33 IST

Gilead Sciences keen to set up unit in Hyderabad

The unit is likely to come up in proposed ‘Pharma City’

December 7, 2015 12:28 IST

Mylan launches Gilead Sciences’ Sovaldi tablets in India

Sovaldi is indicated for the treatment of chronic hepatitis C infection, a blood-borne infectious disease

May 4, 2015 13:25 IST

Natco, Gilead tie up for hepatitis C drugs

Natco Pharma has signed a non-exclusive licensing agreement with US-based Gilead Sciences to manufacture and sell generic versions of its…

March 3, 2015 03:40 IST

Strides Arcolab, Gilead Sciences agreement

To manufacture and distribute Tenofovir Alafenamide (TAF) based HIV treatments in 112 developing countries

January 20, 2015 15:18 IST

Related News

An incorrect name on your Aadhaar can lead to severe issues with KYC (Know Your Customer) compliance, bank accounts, and benefits distribution.

Aadhaar card online update: How to change name, address, date of birth and phone number online in simple steps

Ayushman Bharat scheme benefits: Families with senior citizens get Rs 10 lakh health cover — but there's a catch

Ayushman Bharat scheme: Families with parents above 70 get Rs 10 lakh health cover — but here’s a catch

Lenskart Solutions IPO Subscription Status, GMP price Live

LIVE: Big drop in Lenskart IPO GMP; Premium slips to 11% from peak – Check issue price and key details ahead of Oct 31 opening

Aadhaar Card update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

‘My trust is completely broken’: Marketing head resigns after pay cut, says management is ‘begging’ him to stay

Dabur India Q2 FY26 results: Net profit grows 6.5%, announces dividend of Rs 2.75

Business20 min ago

Dabur India reports 6.5% profit growth in Q2 FY26, with a net profit of Rs 444.79 crore. The company also saw a 5.3% revenue growth, reaching Rs 3,191 crore. An interim dividend of Rs 2.75 per equity share has been announced, with a total payout of Rs 487.76 crore. Q2 FY25 saw a net profit of Rs 417.52 crore and revenue of Rs

View all shorts